Pediatric Mastocytosis: Routine Anesthetic Management for a Complex Disease
- 1 August 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 107 (2), 422-427
- https://doi.org/10.1213/ane.0b013e31817e6d7c
Abstract
BACKGROUND:Pediatric mastocytosis consists of a spectrum of clinical variants characterized by increased numbers of resident mast cells in various organ systems. Mast cells are instrumental in mediating anaphylaxis and patients with mastocytosis are at risk to develop provoked and unprovoked episodeThis publication has 26 references indexed in Scilit:
- Anesthesia in a Patient with Malignant Systemic Mastocytosis using a Total Intravenous Anesthetic TechniqueAnesthesia & Analgesia, 1998
- Anesthesia in a Patient with Malignant Systemic Mastocytosis using a Total Intravenous Anesthetic TechniqueAnesthesia & Analgesia, 1998
- The mast cell and mast cell diseaseJournal of the American Academy of Dermatology, 1995
- The growth and differentiation of mast cellsProgress in Growth Factor Research, 1991
- Urticaria pigmentosa: An anesthetic challengeJournal of Clinical Anesthesia, 1990
- Histamine Release by Four NarcoticsAnesthesia & Analgesia, 1987
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisThe New England Journal of Medicine, 1987
- Hazards in Operative Management of Patients with Systemic MastocytosisAnnals of Surgery, 1983
- Intradermal Histamine Releasing Effect Caused by Org-NC 45 A Comparison with Pancuronium, Metocurine and d-TubocurarineActa Anaesthesiologica Scandinavica, 1980
- Histamine release in manInflammation Research, 1975